Here you can keep up to date with our share price, upcoming events and latest presentations. We invite you to sign up for our email alerts and welcome any questions you may have.
REPCF Market Data
| Corporate Name | RepliCel Life Sciences Inc. |
| Exchange/Symbol | OTCBB/REPCF |
| Exchange/Symbol | CNSX/RP |
| Shares Outstanding | 54,087,210 |
| CUSIP # | 76027P103 |
| ISIN # | CA 76027P1036 |
| Fiscal Year End | December 31 |
| Date of Incorporation | 1967 |
| Incorporated | British Columbia, Canada |
| Industry | Life Sciences |
| Transfer Agent | Computershare |
| Corporate Attorneys | Clark Wilson LLP |
| Auditors | BDO Canada LLP |
Investor Presentation
Click here to view PDF
Recent News
May 23, 2013
April 30, 2013
RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise (more)
Click here to see all news & events posts
Financial Publications
Click here to view all financial publications
Tel: 604-248-8730
Toll Free: 1-800-248-5255
Email:
Corporate Head Office:
RepliCel Life Sciences
1225 – 888 Dunsmuir Street
Vancouver, BC V6C 3K4
Investor Relations Contact
Tammey George, Director of Communications
Direct: 604-248-8696
Email: tg@replicel.com
Sign Up for REPCF Email Alerts
Email notifications can be quickly and conveniently delivered to your e-mail box when information is posted to the site. (Click here)
